Download PDF
1 / Pages

Other users also viewed these articles

Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes Helen K. Reddel; Leonard B. Bacharier; Eric D. Bateman; Christopher E. Brightling; Guy G. Brusselle; Roland Buhl; Alvaro A. Cruz; Liesbeth Duijts; Jeffrey M. Drazen; J. Mark FitzGerald; Louise J. Fleming; Hiromasa Inoue; Fanny W. Ko; Jerry A. Krishnan; Mark L. Levy; Jiangtao Lin; Kevin Mortimer; Paulo M. Pitrez; Aziz Sheikh; Arzu A. Yorgancioglu; Louis-Philippe Boulet;
Arch Bronconeumol. 2022;58:35-51
The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy María Florencia Pilia; María Jesús Cruz; Donghai Ma; Christian Romero-Mesones; David Espejo; Amaia Ojanguren; María Antonia Ramon; Xavier Muñoz; Iñigo Ojanguren;
Arch Bronconeumol. 2023;59:736-42
Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction? Nan Zhao; Samy Suissa; Pierre Ernst;
Arch Bronconeumol. 2023;59:354-5